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Quill and Scope 2017, Volume Nine
Interview with Dean Miller
Quill and Scope Staff
Dr. Donald Douglas Miller is the dean of the School of Med­icine at New York Medical College. He was named to the 
post in 2014 after years of experience in medical research, edu­
cation, and administration. In keeping with the New Frontiers 
theme of this issue of Quill and Sc(}pe, we sat down with Dr. 
Miller to find out more about his past, his vision for the School 
of Medicine, and what this has to do with Wayne Gretzky. This 
interview has been lightly edited and condensed.
Quill & Scope: Your career has spanned many different 
realms. How did you transition from clinical practice and 
research, where it seems like you were in your earlier career, 
to focus more on education and administrative work? What 
got you, or inspired you, to go into medical education?
Dr. Miller: Transition in a career in academic medicine is 
often hard to predict. It often is just situational. Sometimes 
its the person that doesn’t step back when they ask you to 
do something. In my career, I was doing a lot of clinical 
research and clinical care and working in a limited admin­
istrative role [in Saint Louis University]. As good bosses 
and mentors do, my boss said, “Why don’t you take on this 
role and become our key administrator in this hospital and 
make sure that our resident training program there is as 
strong as it can be?” I said, “Sure , I’ll do that.” In the doing 
of that, I also suggested that I get support for an MBA 
that I was going to do at the time, so I did them both at 
the same time and developed a gene for greater interest in 
administration. A couple of years later, having done that, 
he stepped down as the chair, and the Dean asked me if I 
wanted to be the chair of the department. I thought I was 
ready and after consulting with some people I trusted, I 
took that job. That really switched me onto the administra­
tive side.
Q&S: Was the MBA [master’s in business administration] 
sort of a way to buttress your administrative roles and get 
some skills?
DMfYes, I think it was a confidence and skill builder.
Mostly on the management side, less on the financial side, 
although I did both. I’ve used a lot of what I’ve learned and 
have developed since then as a basis for administrative style 
and strategy.
Q&S: Can you speak a little bit about what it’s like to be a 
physician in the business world, where most people who 
get MBAs do not have any science or medical background?
DM: I was the only physician in my MBA class. The group 
of people I worked with was actually an international 
group from all around the world that were doing business 
training. I brought my experience to it and the people from
Monsanto brought 
their experience,
Boeing brought their 
experience, people 
from Budweiser, 
brought the beer. That 
was always good.
You don’t need an 
MBA to be a success­
ful small business 
owner in practice.
You can certainly run 
a practice of a mod­
erate size (as many 
of our colleagues do) 
without any formal 
business training. You do have to learn the skills and ac­
quire the management team that eventually can run it for 
you, because you have time limits and skill limits that pre­
clude that. So the MBA is not a prerequisite to being a good 
physician and small business manager. The modern prac­
tice of medicine has changed in the 20 years since I’ve been 
doing administrative work dramatically. 1996 was when I 
began my administrative role through now. It’s been just 
complete transformation of healthcare delivery. You know 
about what’s going on and many of the drivers of the busi­
ness are changing. But at this point in time, nothing about 
what anybody learned in the past has really prepared them 
for what’s going to happen in the future. It’s very much a 
paradigm shift and a new set of business rewards and risks, 
so that population health and health management, the new 
buzzwords are really just a euphemism for health systems 
becoming more aggregated without any anti-trust concerns 
to prevent it with Obamacare. Secondly, more risk manage­
ment is involved in more of a capitated insurance model, so 
these health systems are actually becoming HMOs [health 
maintenance organizations]. The third part of what is going 
on, which most physicians have really struggled with, is 
data management and large data sets, which your insurer 
already knows about you.
I just had lunch with the dean of Hofstra Medical School. 
Northwell [the healthcare system connected to Hofstra] has 
developed its own insurance company. Their insured clients 
aren't, as he said, sick now, but when you see the other side 
of the data that they’re able to look at, and you realize how 
powerful that health insurance data is, it opens up another 
whole complexity to how we will manage care going for­
ward. I don’t know what I would advise a medical student 
right now, other than to get a good understanding of what 
the broad levers are of the healthcare business.
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Q&S: I remember at the White Coat Ceremony [Aug.
2015], you spoke a lot about how important it is to be edu­
cated and knowledgeable about a lot of these big changes. 
But it seems like the traditional medical curriculum, which 
we have to follow, and we should follow, has very little on, 
if anything, about healthcare systems. It’s a lot of stuff on 
basic and clinical sciences, which are very important. How 
can students really learn more about these larger issues, 
while also trying to pass physiology?
DM: There are certain elements of the curriculum that stan­
dard required elements. Then there are some electives and 
selectives. I think many students work naturally during the 
required elements—you’re pretty much just keeping up with 
the work. You’re a student, you get ready to pass the test 
based on that work. I think the judicious use of research 
time, selective time, and elective time, which currently is 
largely directed towards get­
ting a better residency, could 
be used in a more altruistic 
way to get a better view of the 
world and of what the future 
of medicine will be. I don’t 
want to sound cynical—but I think you can certainly get 
a leg up by doing an elective or selective in orthopedics if 
you want to be an orthopedic surgeon. It’s almost a mantra 
that you need to do—you've got to do research. All these 
things that we have traditionally adopted and advocated for 
are probably still in play. But if you want to get ahead of the 
game, that would be a game changer. One suggestion that 
Dr. Smith [of Hofstra] had was, why don’t you send one of 
your students over to work in our insurance company on 
an elective for a week or two? They’ll learn more about how 
healthcare works than they could ever learn in any class 
and it will be maybe an eye-opener or a career-changer. 
Maybe they’ll develop a whole new area of interest. We 
need to make more of that available. We need to make it 
more relevant to the students that still want to compete 
for their residencies, but maybe also want to have a longer 
view, sort of like selling short, selling long, you get a couple 
of different views to your career.
Q&S: You were quoted [in the Chironian] as saying some­
thing along the lines of, one of the advantages you have 
as coming as having never having been at NYMC before 
is that you bring a fresh perspective. 1 think talking about 
people’s education and population health can be one of 
them. Are there other things you’re trying to implement 
or work on now that come from this place of bringing in a 
fresh pair of eyes to your position?
DM: Yes, I hope so. I try not to be, you know, "Mr. Know- 
it-all." The experience I’ve had in other systems of care, in 
other health systems, and in other parts of the country, I 
hope, has informed what I think works generally, and what 
might be uniquely helpful here. If you spend long enough 
in a sector, you develop a certain playbook of things that 
generally speaking, work. Other things might be a little
riskier, but probably are necessary to take the 
risk. And so, from experience over the course of 
time, building research programs, that we’ve been recently 
developing a strategy in, and we vetted it with our strategic 
plan, to be more translational. Bench to bedside scientists... 
think about not just what goes on in a basic lab, but how 
get it applied.
Q&S: And using current researchers at NYMC to reach that 
goal?
DM: Yes, trying to reinvent and rejuvenate their career 
because, to be fair, and we agree on this—that’s where the 
NIH funding is going. It’s leaving the basic sciences, to 
their chagrin, though not completely. But the new money^ 
is going to precision medicine and cancer, and to more 
translational programs. So we’re trying to build very trans­
lational research programs.
If we can’t do that, then we 
probably won’t be as com­
petitive. Capabilities plus 
partnerships equals compet­
itiveness, is our philosophy. 
That’s true when you’re building educational programs, 
so we talk about the new educational approach with other 
medical schools or nationally, trying to bring in those ideas. 
Faculty development, student programming in new areas of 
concentration, and stuff like that, that we’ve been working 
on. This, I think, works someplace else that I’ve heard about 
it. People are quite receptive to that approach.
Q&S: That’s good that they’re receptive, because you might 
imagine at an old institution like NYMC, there might be 
some resistance to the new guy coming in and with all 
these fresh ideas.
DM: Yes, I think you've got to "build a village" around all 
these issues. There are a lot of people with very good ideas 
and that have done very good work. What I always try to 
do is take time to listen and understand what the platform 
is, talk about it with the stakeholders and the advocates 
for that approach and see if there’s something we can graft 
onto. That's an enhancement that doesn’t require complete 
disruptive change.
Q&S: I think this sort of relates to a role, that I don’t think 
most students know that you have, is that you’re the chief 
scientific officer at BioInc, which is something that we have 
on campus, but I don’t think most students interact with. I 
was wondering if you could ^eak about your role, and what 
is BioInc, and if it really should matter to students at all.
DM: “BioInc at New York Medical College” is descriptive of 
our bioincubator, which is a new company startup envi­
ronment. It’s in the BioInc facilities on Dana Road, where 
the simulation and clinical skills are; on the other side of 
the building there are seven companies. [It hosts] Philips 
Healthcare, big companies, small companies, that are doing 
a combination of biotechnology and high-technology
we're trying to build very transla­
tional research programs.”
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research towards new products. That’s commercialization - 
you’re creating jobs, you’re creating new products. In recent 
weeks, we hosted an event we called the “Pitch Contest.” 
Angel investors came and decided whether they wanted to 
put money into these ideas, to fund them, to the level of 
being commercially viable products. The idea is to foster 
opportunity for both university scientists and investiga­
tors, outside clients, and strategic partnerships with big 
companies. This allows us to help the Philips Healthcare 
research group that was going to^otherwise be moved to 
Massachusetts to be retained in New York. Eleven extreme­
ly well-trained colleagues and scientists, instead of having 
to move to Cambridge, Massachusetts, were able to stay in 
New York and work with our NYMC colleagues on their 
projects. My role is just to help to make sure the science is 
as robust as it can be and that we don’t miss opportunities 
to grow in different sectors. We’re in new drugs, biosensors, 
high-technology, computational genomics, we’re kind of 
taldng advantage of our available options. We like to imag­
ine that we’re the fastest growing, soon-to-be best, incuba­
tor between Downtown Manhattan and Kendall Square, 
Cambridge. That’s the big goal.
Q&S: That would really be something. How do you think 
this should relate to students?
DM: Just like students might like to embed into a health 
insurance company to kind 
of learn how that part of the 
world might work going for­
ward, we have opportunities 
to place students in compa­
nies at Bioinc and give them 
some experience as to what 
it’s like to start up a compa­
ny, to talk with these owners 
of these companies. Some of them might be faculty-oper­
ated, some of them will be corporately-operated, but we’d 
like to imagine that students who want to be innovative and 
might have ideas that they would want to commercialize. 
Students I’ve worked with in the past have developed apps 
for education purposes, and we can help to create intel­
lectual property and protect that for students if they want. 
We-hope students that have research ideas that come out of 
their projects and they actually develop companies—I’ve 
always been amazed at how they have time to actually do 
that, but it’s kind of like working on your 64-Mustang in 
the garage and you just make time on the weekends.
Q&S: Three-year medical programs are getting a lot more 
attention. Can you talk more about whether the college 
here would develop one?
DM: We’ve talked about it hypothetically. One of the other 
schools in Alberta, in Calgary, was a three-year medical 
school. We could compare ourselves to them in many ways 
in quite a detailed manner. Their students completed the 
three-year curriculum, were well-trained and seemed to be
happy. It was all continuous three-year curriculum, there 
were no breaks. They were slightly more mature students. 
They wanted an accelerated program and were willing to 
put up with the limited quality of life that goes on with 
three years of continuous work. They wanted to get it done.
I think there is value to the fourth year if the fourth year 
is part of a well-thought out curriculum that gives all sorts 
of opportunities for enrichment in the four years. If you 
look at the curriculum and said, “Really we could teach this 
curriculum in three years,” get people an MD degree, and 
get them into the workforce or their residency programs 
earlier, it would be nice to offer that to people. But it’s very 
hard to do that as a track. You’ve got to really commit one 
way or the other. It would have to work for everybody. I 
would say, knowing the students and talking the students, I 
think as students, you generally value the work-life balance 
that allows you to move through the work. And sure, you 
can do it quicker, but you wouldn’t have the relationship 
development time, you wouldn’t have the breaks, you 
wouldn’t see your families as much.
Q&S: Such as taking advantage of opportunities like Bio- 
Inc...
DM: Yes, exactly. The enrichment opportunities would be 
limited by that. You can master the curriculum and go 
through it—I think there are very bright students who can
handle the work in three 
years--but it would probably 
change the whole experience. 
The average student that 
I’ve met with really values 
those extra things. It’s my 
feeling that most medical 
schools stay with a four year 
MD program because they 
also believe that that’s in the best interests of the students’ 
well-being, maturation as individuals, as well as their ability 
to have work-life balance.
So probably we won’t do that. We’d like to create more 
value-added opportunities. We have committed to the idea 
that our medical school will have a more progressive cur­
riculum. In the last ten years, that’s meant more integration, 
earlier clinical experience. I’m not convinced of the value of 
[early clinical exposure] even though it’s a widely adopted 
concept that we integrate more clinical work in the early 
years.
Q&S: From my perspective as a student, there seems to 
be some tension from the LCME visit, where there were a 
lot of things that we had to change to be reaccredited. On 
the other hand, there are a lot of things that we would like 
to do independently because we think they’re good ideas. 
How do you balance those things? Now that the LCME visit 
is over, what are some things that are still being worked on?
DM: First of all, we want to be well-accredited by the
... [NYMC has] the fastest grow­
ing, soon-to-be best, incubator be­




LCME. The LCME does require curriculum management 
and curriculum enhancement. Eor example, one of their 
premises is less big classroom didactic, and more small- 
group interactive. We’ve tried to produce a relatively heavy 
classroom content of the past into a kind of 50/50 prop­
osition. We’re not quite there yet. We’re working in that 
direction. I think that’s a good trend.
The other big trend is more clinical experience early, 
because generally speaking, students feel connected to 
why they’re working so hard on the core work in the basic 
sciences if they can sort of see some clinical relevance. So 
we do that with patients and/or simulation in clinical skills, 
so that’s been another trend that I think we’re a part of. 
We’ve caught up, if you will, to those two trends by having 
our own more integrated curriculum and our own better 
clinical skills and simulation capability.
Having done that, then what do you do to really make the 
curriculum more valuable? The new idea, which is extra­
curricular, is areas of concentration, where every student 
will have the opportunity to pursue an area of interest 
or passion for them, whether it’s in biomedical ethics or 
healthcare safety or biomedical research or other areas that 
will be developed. So when you leave, you’ll have commit­
ted to completing the curriculum and it will continue to 
evolve in a related area. You’ll also have this sense that you 
developed a higher understanding of an area that themat­
ically will always be part of your career. You could argue 
that if you did biomedical ethics, you’re always going to be 
thinking about that in a way that’s probably a little bit better 
informed by what you’ve learned than maybe your aver­
age doctor. That is how we’ll drive the curriculum going 
forward.
I think we will also look at novel approaches to expose our 
students to clinical clerkships. The traditional clerkship
model is to embed in a hospital on a clerkship 
rotation. You do the surgical clerkship and in the 
old days, when I was in medical school, patients stayed in 
the hospital for a week, two weeks, around surgery. Now 
they’re in and out. The entire surgery experience involves a 
tremendous amount of pre-work. Patients drop in, may­
be for a day surgery or a two-day admission, and then go 
home for post-op care right out of the hospital. If we’re just 
dropping people into a rotation that says, “Hi Mr. Smith, 
your operation is in three hours. Did you eat anything 
after midnight?” And then they have their procedure and 
they’re leaving by eight o’clock that night—that’s not what 
surgery’s all about anymore. We have to explore and look 
at those current dogmas of medical education that reflect 
the clerkship experience. I’d like to see us put more students 
into multidisciplinary clinic settings. I’d like to see students 
embedded into large practice groups. I’ve visited with the 
Caremount Medical Group, which has multiple primary 
and specialty care capabilities. I think they would be won­
derful partners for a longitudinal integrated clerkshisp.
Q&S: So essentially, you want students to be integrated in 
settings where healthcare as a whole is moving.
DM: Yes, you’re right, exactly. We want to make sure that 
what we do in medical education is relevant to where 
healthcare is going.
Q&S: And not necessarily just the way it was done in past 
years.
DM: Yes, that’s what we’re trying to be. That would be in a 
nutshell, as you said, where we’re trying to be. We’re trying 
to - I'll paraphrase the Gretzky saying - we’re trying to skate 
to where the puck is going, not to where it isn’t.
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